Table III.
Parameter | HR | 95% CI | P-value |
---|---|---|---|
NT-proBNP – RFO Groups: | |||
Group 1 | Reference | ||
Group 2 | 1.16 | 0.59–2.26 | 0.67 |
Group 3 | 1.40 | 0.72–2.75 | 0.32 |
Group 4 | 2.00 | 1.11–3.62 | 0.02 |
Age [years] | 1.04 | 1.02–1.06 | < 0.001 |
Diabetes (0 – no, 1 – yes) | 1.02 | 0.62–1.69 | 0.94 |
Gender (1 – male, 2 – female) | 0.76 | 0.49–1.18 | 0.76 |
Severe NYHA Class (0 – Class 1 and 2, 1 – Class 3 and 4) | 2.04 | 1.06–3.95 | 0.03 |
Hemoglobin [g/dl] | 1.22 | 1.06–1.39 | 0.004 |
Log CRP [mg/dl]* | 1.30 | 1.03–1.64 | 0.03 |
Log phosphorus [mg/dl]* | 0.83 | 0.69–0.99 | 0.04 |
CRP – C-reactive protein, NT-proBNP – N-terminal pro-B-type natriuretic peptide, NYHA – New York Heart Association, RFO – relative fluid overload.
Hazard ratio for each increase in 1 SD in log of the variable.